Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Piracetam for acute ischaemic stroke.

S Ricci1, M G Celani, A T Cantisani

  • 1USL 2, Servizio di Neurologia e Ictus, Via Cestellini, Perugia, 06087, Italy. istitaly@unipg.it

The Cochrane Database of Systematic Reviews
|April 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of fecal bacterial microbiomes according to fecal color, consistency, and sample type in piglets before and after weaning.

Frontiers in veterinary science·2026
Same author

Considering recombinant herpes zoster vaccine for fragile pediatric patients: A new opportunity.

Vaccine·2025
Same author

Wildlife-vehicle collision liability in Europe: A review of existing approaches and their implications.

Journal of environmental management·2025
Same author

How autistic women are aware of their body and take care of their health? Focus on menstruation cycles and gynecological care.

La Clinica terapeutica·2024
Same author

Parents-children co-regulation as therapeutic variable and target in autism spectrum disorders. From observation of drive to need of cooperative parent-mediated therapy.

La Clinica terapeutica·2023
Same author

Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature.

Frontiers in immunology·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Piracetam may increase early death risk in acute stroke patients, though not statistically significant. More research is needed to determine its effects on long-term dependency and functional outcomes.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Piracetam exhibits neuroprotective and antithrombotic properties.
  • These effects suggest potential benefits in reducing mortality and disability following acute stroke.

Purpose of the Study:

  • To evaluate the efficacy and safety of piracetam in patients experiencing acute ischemic stroke.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
  • Searches included major databases (Cochrane, MEDLINE, EMBASE) up to April 2005.
  • Trials included patients treated within 48 hours of stroke onset, with mortality as a primary outcome.

Main Results:

  • Three RCTs with 1002 participants were analyzed; one trial dominated the data.

Related Experiment Videos

  • Piracetam showed a non-significant trend towards increased early mortality, potentially due to baseline stroke severity differences.
  • No significant differences were observed in functional outcomes or dependency between piracetam and control groups.

    • Conclusions:

    • Evidence suggests a possible unfavorable effect of piracetam on early mortality, but this requires further investigation.
    • Insufficient data exists to conclude on piracetam's impact on patient dependency after stroke.
    • Further high-quality trials are needed to clarify piracetam's role in acute stroke management.